Lind Global Fund III LP - 12 Sep 2025 SCHEDULE 13G Report for Silexion Therapeutics Corp Ordinary shares, par value $0.0135 per share (SLXN)

Filing Manager
Lind Global Fund III LP
Reporting Manager
Lind Global Fund III LP
Security
Silexion Therapeutics Corp Ordinary shares, par value $0.0135 per share
Symbol
SLXN
Shares outstanding
2,263,131 shares
Disclosed Ownership
224,050 shares
Ownership
9.9%
Form type
SCHEDULE 13G
Filing time
18 Sep 2025, 17:47:12 UTC
Date of event
12 Sep 2025
Next filing
14 Nov 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Lind Global Fund III LP 9.9% 224,050 224,050 0 By: Lind Global Partners III LLC, its General Partner, By: /s/ Jeff Easton Jeff Easton, Managing Member
Lind Global Partners III LLC 9.9% 224,050 224,050 0 By: Lind Global Partners III LLC, its General Partner, By: /s/ Jeff Easton Jeff Easton, Managing Member
EASTON JEFF 9.9% 224,050 224,050 0 /s/ Jeff Easton Jeff Easton